New study tests migraine drug during active attack
NCT ID NCT06628921
First seen Jan 21, 2026 · Last updated May 24, 2026 · Updated 16 times
Summary
This study looks at whether the migraine drug eptinezumab can stop a migraine attack while it is being infused. Researchers will measure how quickly headache pain and other bothersome symptoms go away. The study involves 50 adults with migraine who are already receiving eptinezumab as part of their regular care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Campus Biomedico
RECRUITINGRoma, Italy
Contact
Conditions
Explore the condition pages connected to this study.